114 related articles for article (PubMed ID: 5115827)
1. Medroxyprogesterone acetate (Provera) in the treatment of metastatic renal cancer.
Bloom HJ
Br J Cancer; 1971 Jun; 25(2):250-65. PubMed ID: 5115827
[TBL] [Abstract][Full Text] [Related]
2. Hormonal treatment of metastases of renal carcinoma.
van der Werf-Messing B; van Gilse HA
Br J Cancer; 1971 Sep; 25(3):423-7. PubMed ID: 5144516
[TBL] [Abstract][Full Text] [Related]
3. Hormonal therapy in advanced renal cell carcinoma.
Wagle DG; Murphy GP
Cancer; 1971 Aug; 28(2):318-21. PubMed ID: 5566354
[No Abstract] [Full Text] [Related]
4. Treatment of the female metastatic hypernephroma.
Tucker WG
Mich Med; 1973 Aug; 72(24):525-8. PubMed ID: 4726736
[No Abstract] [Full Text] [Related]
5. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.
Klaassen DJ; Rapp EF; Hirte WE
Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780
[TBL] [Abstract][Full Text] [Related]
6. The use of progestogen in the treatment of metastatic carcinoma of the kidney and uterine body.
Paine CH; Wright FW; Ellis F
Br J Cancer; 1970 Jun; 24(2):277-82. PubMed ID: 5451569
[TBL] [Abstract][Full Text] [Related]
7. [The treatment of metastasizing hypernephroid (renal cell) carcinoma with medroxyprogesterone acetate (Clinovir) (author's transl].
von Lieven H; Hahn D
MMW Munch Med Wochenschr; 1977 Aug; 119(34):1089-92. PubMed ID: 408657
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant medroxyprogesterone acetate to radical nephrectomy in renal cancer: 5-year results of a prospective randomized study.
Pizzocaro G; Piva L; Di Fronzo G; Giongo A; Cozzoli A; Dormia E; Minervini S; Zanollo A; Fontanella U; Longo G
J Urol; 1987 Dec; 138(6):1379-81. PubMed ID: 2824861
[TBL] [Abstract][Full Text] [Related]
9. [the oral use of a progestational hormone (Provera 100) as an adjuvant in therapy of adenocarcinoma of the kidney. Preliminary report].
Liberti M; Di Silverio F; Concolino G; Tenaglia R; Marocchi A
Minerva Urol; 1980; 32(3):175-8. PubMed ID: 7432332
[TBL] [Abstract][Full Text] [Related]
10. Medroxyprogesterone in metastatic renal cell carcinoma.
Rao MK; Soloway MS
South Med J; 1980 Feb; 73(2):247-8. PubMed ID: 7355330
[TBL] [Abstract][Full Text] [Related]
11. Infarction-nephrectomy for metastatic renal carcinoma. Southwest oncology group study.
Gottesman JE; Crawford ED; Grossman HB; Scardino P; McCracken JD
Urology; 1985 Mar; 25(3):248-50. PubMed ID: 3156442
[TBL] [Abstract][Full Text] [Related]
12. Hormones in the treatment of metastatic renal cancer.
Morales A; Kiruluta G; Lott S
J Urol; 1975 Nov; 114(5):692-3. PubMed ID: 1185861
[TBL] [Abstract][Full Text] [Related]
13. [Experiences with Depo-Provera (medroxyprogesterone) in the treatment of kidney tumors].
Balogh F; Romics I
Z Urol Nephrol; 1987 Aug; 80(8):449-53. PubMed ID: 2961162
[TBL] [Abstract][Full Text] [Related]
14. High-dose medroxyprogesterone acetate in patients with renal adenocarcinoma and measurable lung metastases: a phase II study.
Kjaer M; Frederiksen PL
Cancer Treat Rep; 1986 Mar; 70(3):431-2. PubMed ID: 2937534
[No Abstract] [Full Text] [Related]
15. Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate.
Katakkar SB; Franks CR
Cancer Treat Rep; 1978 Sep; 62(9):1379-80. PubMed ID: 688282
[TBL] [Abstract][Full Text] [Related]
16. Hormonal therapy in metastatic hypernephroma.
Peterson LJ; Grimes JH; Dees JE; Anderson EE
Urology; 1974 Dec; 4(6):669-73. PubMed ID: 4454105
[No Abstract] [Full Text] [Related]
17. Hormone treatment of advanced renal cell carcinoma.
Raghavaiah NV
Urology; 1982 Feb; 19(2):123-6. PubMed ID: 7058601
[No Abstract] [Full Text] [Related]
18. Possible role of hormones in treatment of metastatic testicular teratomas: tumour regression with medroxyprogesterone acetate.
Bloom HJ; Hendry WF
Br Med J; 1973 Sep; 3(5880):563-7. PubMed ID: 4726928
[TBL] [Abstract][Full Text] [Related]
19. Cancer of the urogenital tract: kidney. The basis for hormonal therapy.
Bloom HJ
JAMA; 1968 May; 204(7):605-6. PubMed ID: 5694486
[No Abstract] [Full Text] [Related]
20. Hormonal therapy for metastatic renal cell carcinoma combined androgen and provera followed by high dose tamoxifen.
Papac RJ; Keohane MF
Eur J Cancer; 1993; 29A(7):997-9. PubMed ID: 8499154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
